GLP-1 natural frente a medicamentos: Una comparacin honesta Esta es la pregunta que se hace la mayora de la gente, as que merece una respuesta directa y sincera
In the 1980s, Joel Habener, MD, discovered a gut hormone GLP-1 (glucagon-like peptide-1)that had the potential to stimulate insulin secretion when glucose was elevated, a process generally performed by the pancreas that fails in people with diabetes
It proposes that stimulation of GLP-1 receptors enhances the activity of dopaminergic neurons in the ventral tegmental area (VTA) through a presynaptic mechanism 42
Psychiatric comorbidity as predictor and moderator of binge-eating disorder treatment outcomes: an analysis of aggregated randomized controlled trials
Definitely helped with weight loss and energy too
While semaglutide offers substantial benefits for patients with type 2 diabetes and obesity, its use in hypoglycemic patients requires careful management to mitigate the risk of dizziness and other symptoms associated with low blood sugar